Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pediatric Drugs and Vaccines Market Growth 2022-2028

  • LP 4788750
  • 113 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Pediatric Drugs and Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Pediatric Drugs and Vaccines market size is USD million in 2022 from USD 93410 million in 2021, with a change of % between 2021 and 2022. The global Pediatric Drugs and Vaccines market size will reach USD 174930 million in 2028, growing at a CAGR of 9.4% over the analysis period.

The United States Pediatric Drugs and Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pediatric Drugs and Vaccines market, reaching US$ million by the year 2028. As for the Europe Pediatric Drugs and Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Pediatric Drugs and Vaccines players cover Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), and Eli Lilly and Company (USA), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Drugs and Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Diphtheria

Influenza

Hepatitis

Pneumococcal Diseases

Meningococcal Diseases

Mumps

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Newborn

Infant

Child

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck & Co., Inc. (USA)

Abbott Laboratories (USA)

Amgen, Inc. (USA)

Eli Lilly and Company (USA)

F. Hoffmann-La Roche Ltd (Switzerland)

Genentech, Inc. (USA)

GlaxoSmithKline plc. (UK)

Janssen Biologics B.V. (USA)

Actelion Pharmaceuticals

AstraZeneca Plc. (UK)

Boehringer Ingelheim GmbH (Germany)

Bristol-Myers Squibb Company (USA)

Allergan, Inc. (USA)

Novartis AG (Switzerland)

Novo Nordisk A/S (Denmark)

Pfizer, Inc. (USA)

Sanofi S.A (France)

Shionogi Inc. (USA)

Takeda

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pediatric Drugs and Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pediatric Drugs and Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Pediatric Drugs and Vaccines Segment by Type

2.2.1 Diphtheria

2.2.2 Influenza

2.2.3 Hepatitis

2.2.4 Pneumococcal Diseases

2.2.5 Meningococcal Diseases

2.2.6 Mumps

2.2.7 Others

2.3 Pediatric Drugs and Vaccines Sales by Type

2.3.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pediatric Drugs and Vaccines Sale Price by Type (2017-2022)

2.4 Pediatric Drugs and Vaccines Segment by Application

2.4.1 Newborn

2.4.2 Infant

2.4.3 Child

2.5 Pediatric Drugs and Vaccines Sales by Application

2.5.1 Global Pediatric Drugs and Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pediatric Drugs and Vaccines Sale Price by Application (2017-2022)

3 Global Pediatric Drugs and Vaccines by Company

3.1 Global Pediatric Drugs and Vaccines Breakdown Data by Company

3.1.1 Global Pediatric Drugs and Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Pediatric Drugs and Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Pediatric Drugs and Vaccines Revenue by Company (2020-2022)

3.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Pediatric Drugs and Vaccines Sale Price by Company

3.4 Key Manufacturers Pediatric Drugs and Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pediatric Drugs and Vaccines Product Location Distribution

3.4.2 Players Pediatric Drugs and Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pediatric Drugs and Vaccines by Geographic Region

4.1 World Historic Pediatric Drugs and Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Pediatric Drugs and Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pediatric Drugs and Vaccines Annual Revenue by Geographic Region

4.2 World Historic Pediatric Drugs and Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Pediatric Drugs and Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pediatric Drugs and Vaccines Annual Revenue by Country/Region

4.3 Americas Pediatric Drugs and Vaccines Sales Growth

4.4 APAC Pediatric Drugs and Vaccines Sales Growth

4.5 Europe Pediatric Drugs and Vaccines Sales Growth

4.6 Middle East & Africa Pediatric Drugs and Vaccines Sales Growth

5 Americas

5.1 Americas Pediatric Drugs and Vaccines Sales by Country

5.1.1 Americas Pediatric Drugs and Vaccines Sales by Country (2017-2022)

5.1.2 Americas Pediatric Drugs and Vaccines Revenue by Country (2017-2022)

5.2 Americas Pediatric Drugs and Vaccines Sales by Type

5.3 Americas Pediatric Drugs and Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pediatric Drugs and Vaccines Sales by Region

6.1.1 APAC Pediatric Drugs and Vaccines Sales by Region (2017-2022)

6.1.2 APAC Pediatric Drugs and Vaccines Revenue by Region (2017-2022)

6.2 APAC Pediatric Drugs and Vaccines Sales by Type

6.3 APAC Pediatric Drugs and Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pediatric Drugs and Vaccines by Country

7.1.1 Europe Pediatric Drugs and Vaccines Sales by Country (2017-2022)

7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2017-2022)

7.2 Europe Pediatric Drugs and Vaccines Sales by Type

7.3 Europe Pediatric Drugs and Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pediatric Drugs and Vaccines by Country

8.1.1 Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Pediatric Drugs and Vaccines Sales by Type

8.3 Middle East & Africa Pediatric Drugs and Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pediatric Drugs and Vaccines

10.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines

10.4 Industry Chain Structure of Pediatric Drugs and Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pediatric Drugs and Vaccines Distributors

11.3 Pediatric Drugs and Vaccines Customer

12 World Forecast Review for Pediatric Drugs and Vaccines by Geographic Region

12.1 Global Pediatric Drugs and Vaccines Market Size Forecast by Region

12.1.1 Global Pediatric Drugs and Vaccines Forecast by Region (2023-2028)

12.1.2 Global Pediatric Drugs and Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pediatric Drugs and Vaccines Forecast by Type

12.7 Global Pediatric Drugs and Vaccines Forecast by Application

13 Key Players Analysis

13.1 Merck & Co., Inc. (USA)

13.1.1 Merck & Co., Inc. (USA) Company Information

13.1.2 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Offered

13.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck & Co., Inc. (USA) Main Business Overview

13.1.5 Merck & Co., Inc. (USA) Latest Developments

13.2 Abbott Laboratories (USA)

13.2.1 Abbott Laboratories (USA) Company Information

13.2.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Offered

13.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Abbott Laboratories (USA) Main Business Overview

13.2.5 Abbott Laboratories (USA) Latest Developments

13.3 Amgen, Inc. (USA)

13.3.1 Amgen, Inc. (USA) Company Information

13.3.2 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Offered

13.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Amgen, Inc. (USA) Main Business Overview

13.3.5 Amgen, Inc. (USA) Latest Developments

13.4 Eli Lilly and Company (USA)

13.4.1 Eli Lilly and Company (USA) Company Information

13.4.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Offered

13.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Eli Lilly and Company (USA) Main Business Overview

13.4.5 Eli Lilly and Company (USA) Latest Developments

13.5 F. Hoffmann-La Roche Ltd (Switzerland)

13.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Information

13.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Offered

13.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Main Business Overview

13.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Latest Developments

13.6 Genentech, Inc. (USA)

13.6.1 Genentech, Inc. (USA) Company Information

13.6.2 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Offered

13.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Genentech, Inc. (USA) Main Business Overview

13.6.5 Genentech, Inc. (USA) Latest Developments

13.7 GlaxoSmithKline plc. (UK)

13.7.1 GlaxoSmithKline plc. (UK) Company Information

13.7.2 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Offered

13.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 GlaxoSmithKline plc. (UK) Main Business Overview

13.7.5 GlaxoSmithKline plc. (UK) Latest Developments

13.8 Janssen Biologics B.V. (USA)

13.8.1 Janssen Biologics B.V. (USA) Company Information

13.8.2 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Offered

13.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Janssen Biologics B.V. (USA) Main Business Overview

13.8.5 Janssen Biologics B.V. (USA) Latest Developments

13.9 Actelion Pharmaceuticals

13.9.1 Actelion Pharmaceuticals Company Information

13.9.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Offered

13.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Actelion Pharmaceuticals Main Business Overview

13.9.5 Actelion Pharmaceuticals Latest Developments

13.10 AstraZeneca Plc. (UK)

13.10.1 AstraZeneca Plc. (UK) Company Information

13.10.2 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Offered

13.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 AstraZeneca Plc. (UK) Main Business Overview

13.10.5 AstraZeneca Plc. (UK) Latest Developments

13.11 Boehringer Ingelheim GmbH (Germany)

13.11.1 Boehringer Ingelheim GmbH (Germany) Company Information

13.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Offered

13.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Boehringer Ingelheim GmbH (Germany) Main Business Overview

13.11.5 Boehringer Ingelheim GmbH (Germany) Latest Developments

13.12 Bristol-Myers Squibb Company (USA)

13.12.1 Bristol-Myers Squibb Company (USA) Company Information

13.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Offered

13.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Bristol-Myers Squibb Company (USA) Main Business Overview

13.12.5 Bristol-Myers Squibb Company (USA) Latest Developments

13.13 Allergan, Inc. (USA)

13.13.1 Allergan, Inc. (USA) Company Information

13.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Offered

13.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Allergan, Inc. (USA) Main Business Overview

13.13.5 Allergan, Inc. (USA) Latest Developments

13.14 Novartis AG (Switzerland)

13.14.1 Novartis AG (Switzerland) Company Information

13.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Offered

13.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Novartis AG (Switzerland) Main Business Overview

13.14.5 Novartis AG (Switzerland) Latest Developments

13.15 Novo Nordisk A/S (Denmark)

13.15.1 Novo Nordisk A/S (Denmark) Company Information

13.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Offered

13.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Novo Nordisk A/S (Denmark) Main Business Overview

13.15.5 Novo Nordisk A/S (Denmark) Latest Developments

13.16 Pfizer, Inc. (USA)

13.16.1 Pfizer, Inc. (USA) Company Information

13.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Offered

13.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Pfizer, Inc. (USA) Main Business Overview

13.16.5 Pfizer, Inc. (USA) Latest Developments

13.17 Sanofi S.A (France)

13.17.1 Sanofi S.A (France) Company Information

13.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Offered

13.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Sanofi S.A (France) Main Business Overview

13.17.5 Sanofi S.A (France) Latest Developments

13.18 Shionogi Inc. (USA)

13.18.1 Shionogi Inc. (USA) Company Information

13.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Offered

13.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Shionogi Inc. (USA) Main Business Overview

13.18.5 Shionogi Inc. (USA) Latest Developments

13.19 Takeda

13.19.1 Takeda Company Information

13.19.2 Takeda Pediatric Drugs and Vaccines Product Offered

13.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Takeda Main Business Overview

13.19.5 Takeda Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Pediatric Drugs and Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pediatric Drugs and Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Diphtheria

Table 4. Major Players of Influenza

Table 5. Major Players of Hepatitis

Table 6. Major Players of Pneumococcal Diseases

Table 7. Major Players of Meningococcal Diseases

Table 8. Major Players of Mumps

Table 9. Major Players of Others

Table 10. Global Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)

Table 11. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)

Table 12. Global Pediatric Drugs and Vaccines Revenue by Type (2017-2022) & ($ million)

Table 13. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2022)

Table 14. Global Pediatric Drugs and Vaccines Sale Price by Type (2017-2022) & (USD/Kg)

Table 15. Global Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)

Table 16. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)

Table 17. Global Pediatric Drugs and Vaccines Revenue by Application (2017-2022)

Table 18. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2017-2022)

Table 19. Global Pediatric Drugs and Vaccines Sale Price by Application (2017-2022) & (USD/Kg)

Table 20. Global Pediatric Drugs and Vaccines Sales by Company (2020-2022) & (Kg)

Table 21. Global Pediatric Drugs and Vaccines Sales Market Share by Company (2020-2022)

Table 22. Global Pediatric Drugs and Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2020-2022)

Table 24. Global Pediatric Drugs and Vaccines Sale Price by Company (2020-2022) & (USD/Kg)

Table 25. Key Manufacturers Pediatric Drugs and Vaccines Producing Area Distribution and Sales Area

Table 26. Players Pediatric Drugs and Vaccines Products Offered

Table 27. Pediatric Drugs and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Pediatric Drugs and Vaccines Sales by Geographic Region (2017-2022) & (Kg)

Table 31. Global Pediatric Drugs and Vaccines Sales Market Share Geographic Region (2017-2022)

Table 32. Global Pediatric Drugs and Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Pediatric Drugs and Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Pediatric Drugs and Vaccines Sales by Country/Region (2017-2022) & (Kg)

Table 35. Global Pediatric Drugs and Vaccines Sales Market Share by Country/Region (2017-2022)

Table 36. Global Pediatric Drugs and Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Pediatric Drugs and Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (Kg)

Table 39. Americas Pediatric Drugs and Vaccines Sales Market Share by Country (2017-2022)

Table 40. Americas Pediatric Drugs and Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Pediatric Drugs and Vaccines Revenue Market Share by Country (2017-2022)

Table 42. Americas Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)

Table 43. Americas Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)

Table 44. Americas Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)

Table 45. Americas Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)

Table 46. APAC Pediatric Drugs and Vaccines Sales by Region (2017-2022) & (Kg)

Table 47. APAC Pediatric Drugs and Vaccines Sales Market Share by Region (2017-2022)

Table 48. APAC Pediatric Drugs and Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Pediatric Drugs and Vaccines Revenue Market Share by Region (2017-2022)

Table 50. APAC Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)

Table 51. APAC Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)

Table 52. APAC Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)

Table 53. APAC Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)

Table 54. Europe Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (Kg)

Table 55. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2017-2022)

Table 56. Europe Pediatric Drugs and Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country (2017-2022)

Table 58. Europe Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)

Table 59. Europe Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)

Table 60. Europe Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)

Table 61. Europe Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (Kg)

Table 63. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)

Table 67. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)

Table 69. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Pediatric Drugs and Vaccines

Table 71. Key Market Challenges & Risks of Pediatric Drugs and Vaccines

Table 72. Key Industry Trends of Pediatric Drugs and Vaccines

Table 73. Pediatric Drugs and Vaccines Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Pediatric Drugs and Vaccines Distributors List

Table 76. Pediatric Drugs and Vaccines Customer List

Table 77. Global Pediatric Drugs and Vaccines Sales Forecast by Region (2023-2028) & (Kg)

Table 78. Global Pediatric Drugs and Vaccines Sales Market Forecast by Region

Table 79. Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Pediatric Drugs and Vaccines Sales Forecast by Country (2023-2028) & (Kg)

Table 82. Americas Pediatric Drugs and Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Pediatric Drugs and Vaccines Sales Forecast by Region (2023-2028) & (Kg)

Table 84. APAC Pediatric Drugs and Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Pediatric Drugs and Vaccines Sales Forecast by Country (2023-2028) & (Kg)

Table 86. Europe Pediatric Drugs and Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Pediatric Drugs and Vaccines Sales Forecast by Country (2023-2028) & (Kg)

Table 88. Middle East & Africa Pediatric Drugs and Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Pediatric Drugs and Vaccines Sales Forecast by Type (2023-2028) & (Kg)

Table 90. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Pediatric Drugs and Vaccines Sales Forecast by Application (2023-2028) & (Kg)

Table 94. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 97. Merck & Co., Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Offered

Table 99. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 100. Merck & Co., Inc. (USA) Main Business

Table 101. Merck & Co., Inc. (USA) Latest Developments

Table 102. Abbott Laboratories (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Offered

Table 104. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 105. Abbott Laboratories (USA) Main Business

Table 106. Abbott Laboratories (USA) Latest Developments

Table 107. Amgen, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Offered

Table 109. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 110. Amgen, Inc. (USA) Main Business

Table 111. Amgen, Inc. (USA) Latest Developments

Table 112. Eli Lilly and Company (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Offered

Table 114. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 115. Eli Lilly and Company (USA) Main Business

Table 116. Eli Lilly and Company (USA) Latest Developments

Table 117. F. Hoffmann-La Roche Ltd (Switzerland) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Offered

Table 119. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 120. F. Hoffmann-La Roche Ltd (Switzerland) Main Business

Table 121. F. Hoffmann-La Roche Ltd (Switzerland) Latest Developments

Table 122. Genentech, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Offered

Table 124. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 125. Genentech, Inc. (USA) Main Business

Table 126. Genentech, Inc. (USA) Latest Developments

Table 127. GlaxoSmithKline plc. (UK) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Offered

Table 129. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 130. GlaxoSmithKline plc. (UK) Main Business

Table 131. GlaxoSmithKline plc. (UK) Latest Developments

Table 132. Janssen Biologics B.V. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Offered

Table 134. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 135. Janssen Biologics B.V. (USA) Main Business

Table 136. Janssen Biologics B.V. (USA) Latest Developments

Table 137. Actelion Pharmaceuticals Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 138. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Offered

Table 139. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 140. Actelion Pharmaceuticals Main Business

Table 141. Actelion Pharmaceuticals Latest Developments

Table 142. AstraZeneca Plc. (UK) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 143. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Offered

Table 144. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 145. AstraZeneca Plc. (UK) Main Business

Table 146. AstraZeneca Plc. (UK) Latest Developments

Table 147. Boehringer Ingelheim GmbH (Germany) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 148. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Offered

Table 149. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 150. Boehringer Ingelheim GmbH (Germany) Main Business

Table 151. Boehringer Ingelheim GmbH (Germany) Latest Developments

Table 152. Bristol-Myers Squibb Company (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 153. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Offered

Table 154. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 155. Bristol-Myers Squibb Company (USA) Main Business

Table 156. Bristol-Myers Squibb Company (USA) Latest Developments

Table 157. Allergan, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 158. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Offered

Table 159. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 160. Allergan, Inc. (USA) Main Business

Table 161. Allergan, Inc. (USA) Latest Developments

Table 162. Novartis AG (Switzerland) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 163. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Offered

Table 164. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 165. Novartis AG (Switzerland) Main Business

Table 166. Novartis AG (Switzerland) Latest Developments

Table 167. Novo Nordisk A/S (Denmark) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 168. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Offered

Table 169. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 170. Novo Nordisk A/S (Denmark) Main Business

Table 171. Novo Nordisk A/S (Denmark) Latest Developments

Table 172. Pfizer, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 173. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Offered

Table 174. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 175. Pfizer, Inc. (USA) Main Business

Table 176. Pfizer, Inc. (USA) Latest Developments

Table 177. Sanofi S.A (France) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 178. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Offered

Table 179. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 180. Sanofi S.A (France) Main Business

Table 181. Sanofi S.A (France) Latest Developments

Table 182. Shionogi Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 183. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Offered

Table 184. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 185. Shionogi Inc. (USA) Main Business

Table 186. Shionogi Inc. (USA) Latest Developments

Table 187. Takeda Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 188. Takeda Pediatric Drugs and Vaccines Product Offered

Table 189. Takeda Pediatric Drugs and Vaccines Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 190. Takeda Main Business

Table 191. Takeda Latest Developments

List of Figures

Figure 1. Picture of Pediatric Drugs and Vaccines

Figure 2. Pediatric Drugs and Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pediatric Drugs and Vaccines Sales Growth Rate 2017-2028 (Kg)

Figure 7. Global Pediatric Drugs and Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pediatric Drugs and Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Diphtheria

Figure 10. Product Picture of Influenza

Figure 11. Product Picture of Hepatitis

Figure 12. Product Picture of Pneumococcal Diseases

Figure 13. Product Picture of Meningococcal Diseases

Figure 14. Product Picture of Mumps

Figure 15. Product Picture of Others

Figure 16. Global Pediatric Drugs and Vaccines Sales Market Share by Type in 2021

Figure 17. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2022)

Figure 18. Pediatric Drugs and Vaccines Consumed in Newborn

Figure 19. Global Pediatric Drugs and Vaccines Market: Newborn (2017-2022) & (Kg)

Figure 20. Pediatric Drugs and Vaccines Consumed in Infant

Figure 21. Global Pediatric Drugs and Vaccines Market: Infant (2017-2022) & (Kg)

Figure 22. Pediatric Drugs and Vaccines Consumed in Child

Figure 23. Global Pediatric Drugs and Vaccines Market: Child (2017-2022) & (Kg)

Figure 24. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022)

Figure 25. Global Pediatric Drugs and Vaccines Revenue Market Share by Application in 2021

Figure 26. Pediatric Drugs and Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Pediatric Drugs and Vaccines Revenue Market Share by Company in 2021

Figure 28. Global Pediatric Drugs and Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Pediatric Drugs and Vaccines Revenue Market Share by Geographic Region in 2021

Figure 30. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2017-2022)

Figure 31. Global Pediatric Drugs and Vaccines Revenue Market Share by Country/Region in 2021

Figure 32. Americas Pediatric Drugs and Vaccines Sales 2017-2022 (Kg)

Figure 33. Americas Pediatric Drugs and Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. APAC Pediatric Drugs and Vaccines Sales 2017-2022 (Kg)

Figure 35. APAC Pediatric Drugs and Vaccines Revenue 2017-2022 ($ Millions)

Figure 36. Europe Pediatric Drugs and Vaccines Sales 2017-2022 (Kg)

Figure 37. Europe Pediatric Drugs and Vaccines Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Pediatric Drugs and Vaccines Sales 2017-2022 (Kg)

Figure 39. Middle East & Africa Pediatric Drugs and Vaccines Revenue 2017-2022 ($ Millions)

Figure 40. Americas Pediatric Drugs and Vaccines Sales Market Share by Country in 2021

Figure 41. Americas Pediatric Drugs and Vaccines Revenue Market Share by Country in 2021

Figure 42. United States Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Pediatric Drugs and Vaccines Sales Market Share by Region in 2021

Figure 47. APAC Pediatric Drugs and Vaccines Revenue Market Share by Regions in 2021

Figure 48. China Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Pediatric Drugs and Vaccines Sales Market Share by Country in 2021

Figure 55. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country in 2021

Figure 56. Germany Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country in 2021

Figure 63. Egypt Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Pediatric Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Pediatric Drugs and Vaccines in 2021

Figure 69. Manufacturing Process Analysis of Pediatric Drugs and Vaccines

Figure 70. Industry Chain Structure of Pediatric Drugs and Vaccines

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390